SUN PHARMACEUTICAL INDUSTRIES
|
The Current P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES is 7.85.
Share Price | ₹1,687.6 | Apr 11,2025 |
Market Cap | ₹404,893.9 Cr | |
Sales-TTM | ₹51,602.5 Cr | TTM-Consolidated Results |
Price/Sales | 7.85x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMACEUTICAL INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹404,893.9 Cr] as on Apr 11,2025
(/) Sales [ ₹51,602.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.85x ]
Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay '7.85 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMACEUTICAL INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMACEUTICAL INDUSTRIES
PS Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.18x.
- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/e ratio of 5.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio peaked in Mar2024 at 8.02x.
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio hit its five-year low in Mar2020 of 2.57x.
How does SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES | 51,602.5 | 7.85 | 404,893.9 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.36 | 148,474.0 |
CIPLA LTD | 26,981.2 | 4.38 | 118,166.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.37 | 105,849.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.96 | 92,553.6 |
MANKIND PHARMA LTD | 11,641.0 | 8.33 | 97,009.6 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 3.93 | 87,366.3 |
LUPIN LTD | 22,001.6 | 4.09 | 89,899.9 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.03 | 62,874.7 |
ABBOTT INDIA LTD | 6,243.2 | 10.07 | 62,852.5 |
ALKEM LABORATORIES LTD | 12,756.6 | 4.57 | 58,351.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.03x |
Max industry PS | 16.36x |
Median industry PS | 4.57x |
Average industry PS | 6.72x |
You may also like the below Video Courses